Metabolic dysfunction-associated steatotic liver disease in Asia: implications on management
{{output}}
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 30% of the Asian population, making Asia home to the largest number of patients worldwide. The prevalence of MASLD and its associated complications continues to rise. Notably, certai... ...
